Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.
Traverse-Glehen
A
A
Verney
A
A
Baseggio
L
L
Felman
P
P
Callet-Bauchu
E
E
Thieblemont
C
C
Ffrench
M
M
Magaud
J-P
JP
Coiffier
B
B
Berger
F
F
Salles
G
G
D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000235:genetics* / Q000473:pathology; D008224:Lymphoma, Follicular / Q000235:genetics* / Q000473:pathology; D009154:Mutation / Q000235:genetics*; D051757:PAX5 Transcription Factor / Q000235:genetics*; D051560:Proto-Oncogene Proteins c-bcl-6; D051573:Proto-Oncogene Proteins c-pim-1 / Q000235:genetics*; D013160:Splenic Neoplasms / Q000235:genetics* / Q000473:pathology; D014157:Transcription Factors / Q000235:genetics*; D019014:fas Receptor / Q000235:genetics*; D020741:rho GTP-Binding Proteins / Q000235:genetics*
C084103:BCL6 protein, human; D004268:DNA-Binding Proteins; D051757:PAX5 Transcription Factor; C497281:PAX5 protein, human; D051560:Proto-Oncogene Proteins c-bcl-6; C447841:RhoH protein, human; D014157:Transcription Factors; D019014:fas Receptor; C496634:PIM1 protein, human; D051573:Proto-Oncogene Proteins c-pim-1; D020741:rho GTP-Binding Proteins